Vassallo Steven sold $10.9M of CBRS (indirect holdings)

Vassallo Steven sold 50,000 indirectly-held shares of Cerebras Systems Inc. (CBRS) at an average of $218.18 ($216.38–$219.97, $10.91M total) across 5 trades on 2026-08-14.

Original reporting
SEC EDGAR · Vassallo Steven
Published Aug 18, 2026, 10:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, execution dates, price range, and post-transaction holdings for a director, which can marginally affect sentiment but not fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a sustained repricing.

03

What to watch

The filing notes indirect holdings and no 10b5-1 plan, but it does not disclose the reason for sale or whether other insiders are trading, limiting inference.

Relevance 7/10Novelty 3/10Timing: filed Aug. 18, covering sales executed Aug. 14

Background

The article is an SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems director Vassallo Steven sold about $10.9M of CBRS shares via an open-market sale across five trades on Aug. 14.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and should fade unless followed by additional disclosures.

Evidence & confidence

Form 4 provides transaction details (size, dates, prices) but no new company-specific operating or guidance information. Absence of a 10b5-1 plan can raise scrutiny, yet insider sales are common and not automatically bearish.

Market effects

No clear sector read-through from a single director sale without accompanying company news.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or liquidity needs and may not reflect negative expectations, especially given the multi-trade execution window.

Key entities

  • Cerebras Systems Inc.

    CBRS, the company whose director sold shares as reported on Form 4.

  • Vassallo Steven

    Director who reported an open-market sale of CBRS shares totaling about $10.9M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.